CMA Approves Pharmacy2U's Acquisition of Lloyds Direct

Today the Competition and Markets Authority (CMA) has completed its investigation into Pharmacy2U’s acquisition of Lloyds Direct. The acquisition, which was first announced in September 2023 has now been publicly approved by the CMA.  
 

Since November 2023 when the CMA announced their investigation, both teams from Pharmacy2U and LloydsDirect have been working closely together to assist the CMA with their report.

Kevin Heath – CEO, Pharmacy2U comments

“I am delighted with the outcome of the CMA’s report and I want to personally thank them and both teams at Pharmacy2U and LloydsDirect for assisting the inquiry with the utmost professionalism and transparency during the collaborative process over the past few months. We now embark on an exciting journey to bring together the two businesses’ who going forward will operate under the Pharmacy2U brand. Our patients and the accessible service we offer them remain our top priority through this transition period and beyond”.

CMA Announcement: https://www.gov.uk/cma-cases/pharmacy2u-slash-lloyds-direct-assets-merger-inquiry

Pharmacy2U   

Pharmacy2U is the UK’s largest digital pharmacy. Its mission is to make healthcare more accessible, providing choice and convenience for the whole family when managing health and wellbeing. 

Founded in 1999, and a trusted NHS partner since 2001, Pharmacy2U has revolutionised the repeat prescription industry and is currently the nominated pharmacy for over 800,000 patients. Based in Leeds and Bardon, it is a multi-award-winning business, with patient care at the forefront, supported by 400,000+ reviews and an excellent Trustpilot rating. 

Pharmacy2U offers a wide range of products and services including NHS prescriptions, Health Services, a Private Online Doctor service, Pet Health, and an online pharmacy shop which offers a wide range of health, beauty, and wellness products. 

A proud member of the Company Chemists’ Association (CCA), Pharmacy2U is empowered by innovative technologies to constantly improve healthcare access for its customers. In 2022, the business appointed CEO Kevin Heath to drive forward its vision to become a world-leading digital healthcare provider.